As we head into the new year, New Year’s Resolutions are sure to be top of mind. Try using cannabis to help achieve yours in 2024.
In recreational states, more are considering gifting cannabis for Valentine’s Day – and the CTPharma family shares why this may be. With Valentine’s Day in the air, we wanted to stop and smell the flowers, in more ways than one.
Ever been curious about the content on our labels? Learn more about the information on CTPharma labels.
One of our favorite hybrid legacy strains is back! Introducing the Auralex Flower T35% H 11780!
Novalex is a hybrid strain with a mix of THC and CBD that provides a pungent blueberry smell and a sweet berry flavor.
Square is the perfect shape for concentrate containers - easier to hold and easier to open, with no grooves for product to get stuck under!
This week we are spotlighting the Corleovex RE CR T82% H 11502 and Summit CBD Gamma Flower C22%T1% 11469!
We're channeling our inner serendipity by putting a spin on our Cannabis Infused Drink Mix T10 I Hot Chocolate Flavored 10738! Watch how we've converted a cold weather drink to a summer staple!
The Summit CBD Gamma Flower C22%T1% 11469 has 21.69% CBD and 0.91% THC with 0.55% terpenes.
A CTPharma classic hybrid is coming back around! Introducing the Bandolyn Flower T33% H 11500!
Terpenes are aromatic oils that provide marijuana plants with distinctive flavors, scents and medicinal properties.
One of our hottest topicals is back in action, the Mend T100C100 I Cooling Body Balm 10784!
CTPharma offers a variety of methods for patients to medicate. Here is an explanation of our products, how they work, and how to use them.
CTPharma, a Portland, Connecticut-based medical marijuana producer licensed by the State Department of Consumer Protection today announced that a wholly-owned affiliate of CTPharma -- CTPharma Real Estate Inc. -- has purchased a 216,532 square foot building in Rocky Hill from the pharmaceutical company McKesson Corporation, which had moved out.
Yale School of Medicine and CTPharma announce groundbreaking clinical study with cannabinoid medicines
CTPharma worked for five years to launch an FDA-approved clinical trial in partnership with Yale School of Medicine. Now that the company has the go-ahead, the real work begins.
Yale School of Medicine and CTPharma Announce Groundbreaking Clinical Study with Cannabinoid Medicines on Friday, November 8th at 10:30 a.m. at Yale School of Medicine
Working with UConn, we are examining breeding and cultivation practices in order to create the best products on the market today.